• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 18th December 2018

“You Don’t Always Get What You Want”: Output Distortion and NHS Waiting Time Targets

The latest publication from Professor Graham Cookson in Public Organization Review finds that waiting time targets adopted in the English NHS as part of the ‘targets and terror’ performance management regime did indeed reduce key waiting time measures, but at…

Tim 3
Tim Watson
Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

The latest publication from Professor Graham Cookson in Public Organization Review finds that waiting time targets adopted in the English NHS as part of the ‘targets and terror’ performance management regime did indeed reduce key waiting time measures, but at the expense of other quality metrics such as hospital readmission rates i.e. the policy was output distorting.

In the immortal words of The Rolling Stones, “You don’t always get what you want.” And the latest publication from OHE’s incoming Director, Professor Graham Cookson, demonstrates that in terms of the waiting times targets used in English secondary care this is apparently true in health as well as in love.

The paper, published in Public Organization Review, finds that the waiting time targets that form a part of the infamous ‘targets and terror’ regime suffer from what economists call ‘output distortion’ – reducing waiting times was achieved at the expense of other aspects of care quality. In a political sense at least then, The Rolling Stones were correct “If you try sometimes you find you get what you need.”

Waiting times have long been a concern in the English NHS where healthcare, free at the point of use, is rationed by waiting time. They have been regular fodder for the media and politicians. In response to persistently high waiting times, the English Labour government introduced the use of an aggressive policy of targets coupled with the publication of waiting times data at hospital level (the star-rating) and strong sanctions for poor performing hospital managers. This regime was dubbed ‘targets and terror’.

The policy involved a ratcheting effect. The maximum waiting time for hospital elective care was reduced from 18 months in 2000 to 15 months in 2002, 12 months in 2003, 9 months in 2004 and 6 months in 2005, and finally fell to 18 weeks in 2008. Patients of cancer and cardiovascular diseases should not wait more than two weeks to receive appropriate treatment.

Carol Propper and co-authors have previously demonstrated that the policy worked to lower waiting times through a difference-in-difference approach comparing England (treatment) and Scotland (control) when the policy was first introduced. Generally, clear, measurable targets with hard incentives are expected to work. But their use raises two important concerns: do providers game the system and do they create output distortion effects. The first concern has been well studied, and Hood provides a succinct overview of the problem. The second concern is addressed in this latest paper by OHE’s Graham Cookson.

In essence, the problem is that healthcare organisations have multiple objectives and even within a single objective (e.g. delivering high-quality care) there are multiple dimensions to be considered. However, as Drucker (1974) stated, “what gets measured gets managed.” A major concern then is whether focusing attention, and therefore effort, on meeting targets comes at the cost of poorer performance in other areas which are not measured. This is what economists call output distortion.

The study empirically tests the output distortion theory using data for 161 secondary care trusts in England. The results show a relationship between lower average waiting times and higher readmission rates, a key measure of healthcare quality. As most hospitals are at or are close to full capacity, to reduce or maintain waiting times hospitals must process patients quickly, perhaps discharging some too early which results in higher readmissions rates within 28 days. There is evidence to support the theory of output distortion.

However, shorter waiting times are associated with higher patient-reported health gains. There is an intuitive explanation. Hospitals could meet the waiting time targets by improving their general performance, especially their efficiency e.g. moving to day patient surgery. Other hospitals could meet the waiting time targets by freeing up beds by discharging patients too early. 

It is clear that if the ultimate aim of the policy is to reduce waiting times by improving the efficiency of hospitals, then a waiting time target by itself does not guarantee this. Policymakers must, therefore, be mindful of potentially perverse outcomes such as output distortion when setting targets in the public sector. However, if policymakers and politicians only care about reducing waiting times then The Rolling Stones were correct “If you try sometimes you find you get what you need.”

Citation

Elkomy, S. and Cookson, G., 2018. Performance Management Strategy: Waiting Time in the English National Health Services. Public Organisation Review. DOI.

Related research

Siciliani, L., 2016. Waiting Time Policies in the Health Sector. OHE Seminar Briefing. RePEc.

  • Healthcare Systems
  • Policy, Organisation and…
  • External Publications

Related News

  • News
  • September 2020

Establishing a Reasonable Price for an Orphan Drug

Read more
  • News
  • April 2020

Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support

Read more
  • News
  • April 2020

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

Read more
  • News
  • February 2020

Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!